Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1517-1526
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1517
Table 1 Comparison of baseline data between the two groups, n (%)
Parameters
Control group (n = 65)
Observation group (n = 65)
χ2/t
P value
Age (yr)63.12 ± 12.0562.85 ± 11.540.1300.896
Course of disease (yr)12.24 ± 3.0212.31 ± 2.840.1360.892
IPSS score 30.56 ± 4.6331.02 ± 4.810.5550.580
Prostate volume (mL)45.96 ± 7.8646.21 ± 7.370.1870.852
Rectal digital examination
II degree36 (55.38)41 (63.08)0.7960.372
III degree29 (44.62)24 (36.92)
Basic diseases
Bladder stones24 (36.92)19 (29.23)0.8690.351
Hypertension36 (55.38)39 (60.00)0.2840.594
Diabetes18 (27.69)20 (30.77)0.1490.700
Coronary heart disease27 (41.54)22 (33.85)0.8190.366
Chronic obstructive pulmonary disease25 (38.46)23 (35.38)0.1320.716
Table 2 Comparison of postoperative outcomes between the two groups (mean ± SD)
Group
Number of cases
Postoperative exhaust time (h)
Time of indwelling catheter (d)
Hospitalization time (d)
Control group6524.63 ± 4.515.63 ± 1.2410.23 ± 2.28
Observation Group6518.65 ± 3.234.85 ± 1.088.78 ± 2.03
t8.6913.8243.829
P value0.0000.0000.000
Table 3 Comparison of urinary flow mechanics index, international prostate system score and incontinence quality of life questionnaire score in the two groups (mean ± SD)
Group
Control group (n = 65)
Observation group (n = 65)
t
P value
MUCP (cmH2O)Preoperative24.12 ± 4.3324.05 ± 4.560.090.929
Postoperative25.69 ± 4.1325.47 ± 4.320.2970.767
RUV (mL)Preoperative74.21 ± 15.6673.25 ± 16.740.3380.736
Postoperative16.23 ± 3.21a13.14 ± 2.57a6.0580
Qmax (mL/s)Preoperative4.26 ± 1.234.31 ± 1.270.2280.82
Postoperative11.45 ± 2.03a13.65 ± 2.41a5.6290
IPSS scorePreoperative30.56 ± 4.6331.02 ± 4.810.5550.58
Postoperative8.96 ± 1.56a5.74 ± 1.04a13.8460
I-QOL scorePreoperative40.43 ± 4.5240.68 ± 5.060.2970.767
Postoperative48.74 ± 3.62a51.14 ± 3.05a4.0880
Table 4 Comparison of complications between two groups, n (%)
Group
Number of cases
Urethral orifice injury
Bladder spasm
Secondary bleeding
Control group652 (3.08)1 (1.54)3 (4.62)
Observation group651 (1.54)0 (0.00)1 (1.54)
χ20.3411.0081.032
P value0.5590.3150.310
Table 5 Comparison of urinary incontinence between two groups, n (%)
Group
Number of cases
Urinary incontinence
Duration of urinary incontinence
Mild
Moderate
Severe
Total
< 1 wk
1 wk-4 wk
> 4 wk
Control group6510 (40.00)11 (44.00)4 (16.00)25 (38.46)13 (52.00)8 (32.00)4 (16.00)
Observation group657 (50.00)5 (35.71)2 (14.29)14 (21.54)9 (64.29)5 (35.71)0 (0.00)
χ24.3222.517
P value0.0350.284